1
TITLE: FINAL Analysis of a PAN European STOP Tyrosine Kinase Inhibitor Trial in Chronic Myeloid Leukemia : The EURO-SKI Study
AUTHORS: Mahon, Francois Xavier; Richter, Johan; Hochhaus, Andreas; Panayiotidis, Panayiotis; de Almeida, Antonio Medina; Mayer, Jiri; Hjorth Hansen, Henrik; Janssen, Jeroen; Mustjoki, Satu; Martinez Lopez, Joaquin; Vestergaard, Hanne; Ehrencrona, Hans; Kairisto, Veli; Dulucq, Stephanie; Machova, Katerina; Nicolini, Franck E.; Hofmann, Wolf Karsten; Guilhot, Joelle; Saussele, Susanne; Pfirrmann, Markus;
PUBLISHED: 2021, SOURCE: BLOOD, VOLUME: 138, ISSUE: Supplement 1
INDEXED IN: WOS CrossRef: 7
2
TITLE: Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial  Full Text
AUTHORS: Saussele, S; Richter, J; Guilhot, J; Gruber, FX; Hjorth Hansen, H; Almeida, A; Janssen, JJWM; Mayer, J; Koskenvesa, P; Panayiotidis, P; Olsson Strömberg, U; Martinez Lopez, J; Rousselot, P; Vestergaard, H; Ehrencrona, H; Kairisto, V; Machová Poláková, K; Müller, MC; Mustjoki, S; Berger, MG; Fabarius, A; Hofmann, WK; Hochhaus, A; Pfirrmann, M; Mahon, FX; Ossenkoppele, G; Pagoni, MN; Söderlund, S; Escoffre Barbe, M; Etienne, G; Dengler, J; Huguet, F; von Bubnoff, N; Klamova, H; Faber, E; Guilhot, F; Lotfi, K; Rea, D; Brümmendorf, TH; de Greef, GE; Stenke, L; Nicolini, FE; Legros, L; Burchert, A; Voglova, J; Charbonnier, A; Gyan, E; Kunzmann, V; Westerweel, PE; ...More
PUBLISHED: 2018, SOURCE: LANCET ONCOLOGY, VOLUME: 19, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 476
3
TITLE: Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-alpha Monotherapy  Full Text
AUTHORS: Mette Ilander; Anna Kreutzman; Peter Rohon; Teresa Melo; Edgar Faber; Kimmo Porkka; Jukka Vakkila; Satu Mustjoki;
PUBLISHED: 2014, SOURCE: PLOS ONE, VOLUME: 9, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef
4
TITLE: Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy  Full Text
AUTHORS: Mustjoki, S; Auvinen, K; Kreutzman, A; Rousselot, P; Hernesniemi, S; Melo, T; Lahesmaa Korpinen, AM; Hautaniemi, S; Bouchet, S; Molimard, M; Smykla, R; Lee, FY; Vakkila, J; Jalkanen, S; Salmi, M; Porkka, K;
PUBLISHED: 2013, SOURCE: LEUKEMIA, VOLUME: 27, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef
5
TITLE: Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia  Full Text
AUTHORS: Anna Kreutzman; Taina Jaatinen; Dario Greco; Emmi Vakkila; Johan Richter; Marja Ekblom; Henrik Hjorth Hansen; Leif Stenke; Teresa Melo; Ron Paquette; Ruth Seggewiss Bernhardt; Agnes Guerci Bresler; Alexis Talbot; Jean Michel Cayuela; Francois Xavier Mahon; Kimmo Porkka; Jeff Lipton; Jukka Partanen; Philippe Rousselot; Satu Mustjoki;
PUBLISHED: 2012, SOURCE: EXPERIMENTAL HEMATOLOGY, VOLUME: 40, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef
6
TITLE: Dasatinib Induces a Rapid, Dose-Controllable Mobilization of Cytotoxic Lymphocytes: A Novel Immunomodulatory Effect Associated With Prolonged Therapy Responses In Advanced Leukemia.
AUTHORS: Satu Mustjoki; Philippe Rousselot; Sari Jalkanen; Anna Kreutzman; Teresa Melo; Anna Maria Lahesmaa; Sampsa Hautaniemi; Mathieu Molimard; Richard Smykla; Francis Lee; Jukka Vakkila; Kimmo Porkka;
PUBLISHED: 2010, SOURCE: 52nd Annual Meeting of the American-Society-of-Hematology (ASH) in BLOOD, VOLUME: 116, ISSUE: 21
INDEXED IN: WOS